Clinical trials
Recruiting Cholangiocarcinoma trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Seoul National University Hospital | 2 |
| Aichi Medical University | 1 |
| Bold Therapeutics, Inc. | 1 |
| CHA University | 1 |
| DualityBio Inc. | 1 |
| Fore Biotherapeutics | 1 |
| Jazz Pharmaceuticals | 1 |
| Samsung Medical Center | 1 |
| Taiho Oncology, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cholangiocarcinoma | 10 |
| Biliary Tract Neoplasms | 5 |
| Breast Neoplasms | 2 |
| Carcinoma, Hepatocellular | 2 |
| Colorectal Neoplasms | 2 |
| Gallbladder Neoplasms | 2 |
| Liver Neoplasms | 2 |
| Pancreatic Neoplasms | 2 |
| Stomach Neoplasms | 2 |
| Bile Duct Neoplasms | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.